Fjarde Ap-fonden’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.6M | Buy |
91,088
+17,200
| +23% | +$7.66M | 0.37% | 53 |
|
2025
Q1 | $35.8M | Buy |
73,888
+5,800
| +9% | +$2.81M | 0.43% | 43 |
|
2024
Q4 | $27.4M | Sell |
68,088
-3,900
| -5% | -$1.57M | 0.28% | 67 |
|
2024
Q3 | $33.5M | Buy |
+71,988
| New | +$33.5M | 0.34% | 52 |
|
2024
Q1 | $29.7M | Buy |
70,988
+2,000
| +3% | +$836K | 0.33% | 57 |
|
2023
Q4 | $28.1M | Sell |
68,988
-2,500
| -3% | -$1.02M | 0.35% | 51 |
|
2023
Q3 | $24.9M | Sell |
71,488
-1,200
| -2% | -$417K | 0.33% | 55 |
|
2023
Q2 | $25.6M | Buy |
72,688
+6,700
| +10% | +$2.36M | 0.31% | 59 |
|
2023
Q1 | $20.8M | Sell |
65,988
-900
| -1% | -$284K | 0.28% | 79 |
|
2022
Q4 | $19.3M | Sell |
66,888
-34,898
| -34% | -$10.1M | 0.27% | 81 |
|
2022
Q3 | $28.7M | Hold |
101,786
| – | – | 0.36% | 54 |
|
2022
Q2 | $28.7M | Buy |
101,786
+31,700
| +45% | +$8.93M | 0.36% | 54 |
|
2022
Q1 | $18.3M | Sell |
70,086
-401
| -0.6% | -$105K | 0.18% | 109 |
|
2021
Q4 | $15.5M | Sell |
70,487
-700
| -1% | -$154K | 0.14% | 142 |
|
2021
Q3 | $12.9M | Sell |
71,187
-548
| -0.8% | -$99.4K | 0.12% | 164 |
|
2021
Q2 | $14.5M | Sell |
71,735
-5,600
| -7% | -$1.13M | 0.13% | 153 |
|
2021
Q1 | $16.6M | Buy |
77,335
+300
| +0.4% | +$64.5K | 0.15% | 134 |
|
2020
Q4 | $18.2M | Sell |
77,035
-2,300
| -3% | -$544K | 0.17% | 120 |
|
2020
Q3 | $21.6M | Buy |
79,335
+5,300
| +7% | +$1.44M | 0.24% | 84 |
|
2020
Q2 | $21.5M | Buy |
74,035
+4,342
| +6% | +$1.26M | 0.27% | 72 |
|
2020
Q1 | $16.6M | Sell |
69,693
-300
| -0.4% | -$71.4K | 0.27% | 74 |
|
2019
Q4 | $15.3M | Buy |
69,993
+4,400
| +7% | +$963K | 0.19% | 115 |
|
2019
Q3 | $11.1M | Buy |
65,593
+1,400
| +2% | +$237K | 0.14% | 164 |
|
2019
Q2 | $11.8M | Sell |
64,193
-7,500
| -10% | -$1.38M | 0.15% | 151 |
|
2019
Q1 | $13.2M | Buy |
71,693
+12,033
| +20% | +$2.21M | 0.17% | 127 |
|
2018
Q4 | $9.89M | Sell |
59,660
-7,700
| -11% | -$1.28M | 0.17% | 124 |
|
2018
Q3 | $13M | Sell |
67,360
-2,902
| -4% | -$559K | 0.19% | 115 |
|
2018
Q2 | $11.9M | Buy |
70,262
+254
| +0.4% | +$43.2K | 0.18% | 123 |
|
2018
Q1 | $11.4M | Buy |
70,008
+744
| +1% | +$121K | 0.17% | 129 |
|
2017
Q4 | $10.4M | Buy |
69,264
+10,892
| +19% | +$1.63M | 0.16% | 142 |
|
2017
Q3 | $8.88M | Buy |
58,372
+1,122
| +2% | +$171K | 0.17% | 135 |
|
2017
Q2 | $7.38M | Buy |
57,250
+6,788
| +13% | +$875K | 0.15% | 153 |
|
2017
Q1 | $5.52M | Sell |
50,462
-2,962
| -6% | -$324K | 0.13% | 173 |
|
2016
Q4 | $3.94M | Sell |
53,424
-5,445
| -9% | -$401K | 0.09% | 248 |
|
2016
Q3 | $5.13M | Buy |
58,869
+1,508
| +3% | +$132K | 0.11% | 210 |
|
2016
Q2 | $4.93M | Buy |
57,361
+1,438
| +3% | +$124K | 0.11% | 206 |
|
2016
Q1 | $4.45M | Buy |
55,923
+7,338
| +15% | +$583K | 0.1% | 221 |
|
2015
Q4 | $6.11M | Buy |
48,585
+1,127
| +2% | +$142K | 0.16% | 143 |
|
2015
Q3 | $4.94M | Sell |
47,458
-3,459
| -7% | -$360K | 0.14% | 171 |
|
2015
Q2 | $6.29M | Sell |
50,917
-3,267
| -6% | -$403K | 0.15% | 156 |
|
2015
Q1 | $6.39M | Sell |
54,184
-2,204
| -4% | -$260K | 0.15% | 163 |
|
2014
Q4 | $6.7M | Sell |
56,388
-4,606
| -8% | -$547K | 0.15% | 163 |
|
2014
Q3 | $6.85M | Sell |
60,994
-5,223
| -8% | -$587K | 0.15% | 156 |
|
2014
Q2 | $6.27M | Sell |
66,217
-1,138
| -2% | -$108K | 0.12% | 184 |
|
2014
Q1 | $4.76M | Buy |
67,355
+2,396
| +4% | +$169K | 0.09% | 242 |
|
2013
Q4 | $4.83M | Sell |
64,959
-404
| -0.6% | -$30K | 0.1% | 221 |
|
2013
Q3 | $4.96M | Sell |
65,363
-19,014
| -23% | -$1.44M | 0.11% | 215 |
|
2013
Q2 | $6.74M | Buy |
+84,377
| New | +$6.74M | 0.14% | 159 |
|